(R)-1-(Pyridin-2-yl)ethanamine dihydrochloride, 95.0%, 1g

4-Iodoisoquinoline, 95.0%, 5g

2-Amino-2-(3,4-dihydroxyphenyl)acetic acid, 95%, 1g

2,3,4,5-Tetrahydrobenzo[f][1,4]oxazepine hydrochloride, 95.0%, 5g

7-Chloro-3-isopropyl-5-methylsulfanyl-1h-pyrazolo[4,3-d]pyrimidine, 95+%, 5g

4-(2-Methyl-1H-imidazol-1-yl)benzoic acid, >95%, 1g

2-(2,4-Dimethylphenoxy)propanohydrazide, 95.0%, 1g

Butildiglicol, mínimo 97 %, puro, 2,5 l, envase de vidrio

(4-Iodo-cyclohexyl)-carbamic acid tert-butyl ester, 97.0%, 5g

4-Methoxy-2-(pyrrolidin-3-yloxy)pyridinedihydrochloride, 1g

2-(4-Fluorophenoxy)acetohydrazide, 98.0%, 10g

((1,3-Dioxolan-2-yl)methyl)tributylphosphonium bromide, 97%, 1g

1-Hydroxycyclobutanecarboxylic acid, 97.0%, 250mg